Table 1 Patient demographics of the blood plasma samples used within this study.
From: Rationalising the role of Keratin 9 as a biomarker for Alzheimer’s disease
Healthy Cohort | AD Cohort | |
|---|---|---|
Sample number | 60 | 58 |
Gender (M/F) | 25/35 | 31/27 |
Age at entry (years ± SD) | 80.33 ± 6.64 | 79.03 ± 6.96 |
Time between study entry and recalled onset (years ± SD) | — | 4.32 ± 2.71 |
